Home
>
Seminars
>
Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging
|
Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging
By Frédéric Ducongé (CEA, I2BM, SHFJ - INSERM U1023).
May 27, 2013 at 11:00AM - Salle de réunion du LJP
|
Abstract
Frédéric Ducongé will give a talk on "Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging".